Choose License Type
The global medical fluid bags market was valued at USD 3.07 billion in 2020 and is projected to grow at a CAGR of 6.7% during the forecast period. Factors driving the growth of the medical fluid bags market include increasing popularity of chronic ailments, increasing number of surgical procedures and surging aged population.
Medical solution and blood bags are used in various clinical applications nowadays. Classically prepared from sheets of PVC, EVA or polyolefin which are closed at their outside edges, they frequently have tubes or ports leaving the bags inside and sealed between the flat sheets.
Regionally, Europe accounted for the largest market share of the global medical fluid bags market attributable to favourable reimbursement policies. Leading players of the global medical fluid bags market include Amsino, Baxter, B. Braun, C.R.Bard, ConvaTec, Coloplast, Eagle, Hospira, Fresenius Kabi, Kawasumi Laboratories, Pall Corporation among others.
Key segments of the global medical fluid bags market
Product Overview, 2018-2028 (USD Billion)
End-Use Overview, 2018-2028 (USD Billion)
Regional Overview, 2018-2028 (USD Billion)
Reasons for the study
What does the report include?
Who should buy this report?
Technologies are shifting day by day. To keep up with it, technologies in medical field are also moving and developing. Progressions in medical technology have permitted doctors to better analyze and treat their patients ever since the beginning of the proficient practice of medicine. In today’s world, technology plays a vital role in every industry along with in our private lives. Out of all of the industries that technology plays a central role in, healthcare is certainly one of the utmost important. This union is accountable for refining and saving numerous lives all round the sphere. In earlier few years there has been countless work expended by researchers in a medical field for developing fluid bags. The benefit of such a system is that it would enable the physician to monitor and control the fluid system at the comfort of his/her office and there is no need of continuous presence of him.
The global medical fluid bags market is categorized based on product and end-use.
By product: The drain bags dominated the market in 2020 due to increasing dominance of kidney linked ailments for instance renal failure, hypertension and diabetes amid aged inhabitants leading to growing number of operating procedures.
By end-use: The blood banks dominated the market in 2020 due to rising number of blood banks in established and emerging nations together with government support for increasing cognizance regarding blood donation.
In the global medical fluid bags market, Asia Pacific is set to observer fastest growth rate through the forecast period due rapidly ageing population. In 1950, the elderly in Asia numbered roughly 57.6 million and accounted for no more than 4.1% of the region’s population. By the middle of this century, the elderly population is projected to reach 922.7 million, and their share is expected to rise to 17.5%. Asia accounted for only 44% of the global elderly population in 1950, but by 2050, this share is projected to increase to 62%. The demographic transition towards an aging population is more advanced in developed countries like Japan and in People’s Republic of China and the newly-industrialized economies Hong Kong, China; Republic of Korea (Korea); and Singapore. However, many of the developing countries in the region are on the same demographic path, and they are making the transition at a much faster rate.
The global medical fluid bags market was valued at USD 3.07 billion in 2020 and is projected to grow at a CAGR of 6.7% during the forecast period. Factors driving the growth of the medical fluid bags market include increasing popularity of chronic ailments, increasing number of surgical procedures and surging aged population.
Medical solution and blood bags are used in various clinical applications nowadays. Classically prepared from sheets of PVC, EVA or polyolefin which are closed at their outside edges, they frequently have tubes or ports leaving the bags inside and sealed between the flat sheets.
Regionally, Europe accounted for the largest market share of the global medical fluid bags market attributable to favourable reimbursement policies. Leading players of the global medical fluid bags market include Amsino, Baxter, B. Braun, C.R.Bard, ConvaTec, Coloplast, Eagle, Hospira, Fresenius Kabi, Kawasumi Laboratories, Pall Corporation among others.
Key segments of the global medical fluid bags market
Product Overview, 2018-2028 (USD Billion)
End-Use Overview, 2018-2028 (USD Billion)
Regional Overview, 2018-2028 (USD Billion)
Reasons for the study
What does the report include?
Who should buy this report?
1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.2.1. Primary Sources
2.2.2. Secondary Sources
2.3. Market Size Estimation
2.4. Market Forecast
2.5. Data Triangulation
2.6. Assumptions and Limitations
3. Executive Summary
4. Market Outlook
4.1. Introduction
4.2. Market dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porter’s five forces analysis
4.4. Value chain analysis
4.5. COVID-19 impact analysis
5. Medical fluid bags Market by Product, 2018-2028 (USD Billion)
5.1. Introduction
5.2. Blood bags
5.3. Intravenous bags
5.4. Drain bags
5.5. Enema bags
5.6. Biohazard disposable bags
5.7. Breast milk bags
5.8. Reagent bags
5.9. Dialysis bags
5.10. Others
6. Medical fluid bags Market by End-use, 2018-2028 (USD Billion)
6.1. Introduction
6.2. Hospital
6.3. Blood banks
6.4. Clinics
6.5. Homecare settings
6.6. Diagnostic centers
7. Medical fluid bags Market by Region, 2018-2028 (USD Billion)
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. UK
7.2.2. France
7.2.3. Germany
7.2.4. Rest of Europe
7.3. Asia Pacific
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. Rest of Asia Pacific
7.4. South America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Rest of South America
7.5. Middle East and Africa
7.5.1. GCC
7.5.2. South Africa
7.5.3. Rest of Middle East & Africa
8. Competitive Landscape
8.1. Introduction
8.2. Strategic initiatives
8.2.1. Mergers & acquisitions
8.2.2. New product launch
8.2.3. Investments
8.2.4. Expansion
8.2.5. Others
9. Company Profiles
(Overview, Products and Services Portfolio, Recent Initiatives, Company Financials)
9.1. Amsino
9.2. Baxter
9.3. B. Braun
9.4. C.R.Bard
9.5. ConvaTec
9.6. Coloplast
9.7. Eagle
9.8. Hospira
9.9. Fresenius Kabi
9.10. Kawasumi Laboratories